Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home
31 items matching your search terms.
Filter the results.
Item type














New items since



Sort by relevance · date (newest first) · alphabetically
2013 UCRF Innovation Awards announced
by William Shawn Davis (wishda) published Jul 23, 2013 last modified Aug 06, 2013 03:04 PM — filed under:
UCRF Competitive Grants Program 2013 Innovation Awards were chosen from 51 applications. The awards provided $1,180,000 to support research among the six winners.
Located in News
Basch - National standards to evaluate health care quality based on how patients feel
by William Shawn Davis (wishda) published Jul 11, 2013 last modified Jul 11, 2013 02:45 PM — filed under:
National quality assessment programs usually measure and reward practices based on improving clinical processes such as re-hospitalization or infection rates. While this type of information is important and useful to clinicians, it doesn’t always take into account what is most important to the patient and families of the patient receiving care, such as the management of long-term symptoms or ability to conduct daily activities.
Located in News
Basch: Patient participation must play a larger role in research
by William Shawn Davis published May 13, 2013 last modified May 13, 2013 04:05 PM — filed under:
Patients must take a larger role in participating in and assisting in determining priorities for medical research, according to an editorial published in an upcoming issue of the Journal of the American Medical Association.
Located in News
Cancer patient out-of-pocket costs play major role in treatment adherence
by William Shawn Davis (wishda) published Jan 09, 2014 — filed under:
The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient’s share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina.
Located in News
Dees and Hayes named co-leaders of UNC Lineberger Clinical Research Program
by William Shawn Davis published May 20, 2013 — filed under:
Claire Dees, MD, and Neil Hayes, MD, MPH, have been appointed as co-leaders of the Clinical Research Program at UNC Lineberger Comprehensive Cancer Center. Dr. Dees and Hayes have extensive and complementary expertise in translational and clinical research. As co-leaders of the Clinical Research Program, they will help plan the efforts of UNC Lineberger’s physician researchers to move discoveries into innovative trials of new therapeutic approaches.
Located in News
Dees and Hayes named co-leaders of UNC Lineberger Clinical Research Program
by William Shawn Davis published May 09, 2013 — filed under:
Claire Dees, MD, and Neil Hayes, MD, MPH, have been appointed as co-leaders of the Clinical Research Program at UNC Lineberger Comprehensive Cancer Center. Dr. Dees and Hayes have extensive and complementary expertise in translational and clinical research. As co-leaders of the Clinical Research Program, they will help plan the efforts of UNC Lineberger’s physician researchers to move discoveries into innovative trials of new therapeutic approaches.
Located in Old top news stories
DeSimone microneedle patch featured in ScienceNews
by William Shawn Davis (wishda) published Aug 12, 2013 — filed under:
A rapidly-dissolvable microneedle patch developed by a UNC team led by Joseph DeSimone, William R. Kenan, Jr. Distinguished Professor of Chemistry and Chemical Engineering, and director of the UNC Institute for Advanced Materials, Nanoscience, and Technology and member of UNC Lineberger, allows for painless injections of medicine and vaccines.
Located in News
Goldstein profiled in The Journal of Cell Biology
by William Shawn Davis (wishda) published Aug 09, 2013 last modified Aug 09, 2013 11:24 AM — filed under:
Bob Goldstein, PhD, professor of biology, talks about his career and the promise of cell biology in a profile in the August issue of The Journal of Cell Biology.
Located in News
IMRT may not be more effective than older radiation techniques after prostatectomy
by William Shawn Davis published May 20, 2013 last modified May 21, 2013 08:18 AM — filed under:
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.
Located in Old top news stories
IMRT may not be more effective than older radiation techniques after prostatectomy
by William Shawn Davis (wishda) published May 28, 2013 — filed under:
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.
Located in News